Added to YB: 2021-06-09
Pitch date: 2021-06-09
MRK [bullish]
Merck & Co., Inc.
+88.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
Market Cap
$302.0B
Pitch Price
$64.75
Price Target
N/A
Dividend
2.79%
EV/EBITDA
11.29
P/E
16.71
EV/Sales
5.00
Sector
Pharmaceuticals
Category
N/A
Show full summary:
MERCK & CO MRK
A summary for this pitch has not been created yet.
Read full article (0 min)